{"id":20808,"date":"2023-10-26T17:14:04","date_gmt":"2023-10-26T15:14:04","guid":{"rendered":"https:\/\/ggba.swiss\/?p=20808"},"modified":"2023-10-26T17:14:05","modified_gmt":"2023-10-26T15:14:05","slug":"debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/","title":{"rendered":"Debiopharm invests CHF 30 million in Valais amidst workforce surge"},"content":{"rendered":"\n

The pharmaceutical sector in Valais is set for a boost as Debiopharm Research & Manufacturing (Debiopharm<\/a>) unveils plans for a new Innovation building in Martigny. This major investment comes in tandem with a 33% growth in its workforce in the region.<\/p>\n\n\n\n

The groundbreaking ceremony was graced by dignitaries such as Christophe Darbelley, President of the Valais State Council, and representatives from the Valais School of Engineering<\/a>. The new building, which represents an investment of over CHF 30 million, strengthens Debiopharm’s ongoing CHF 150 million initiative started in 2000. These investments have largely been directed towards renovating laboratories and modernizing the production plant.<\/p>\n\n\n\n

The plant’s primary product, triptorelin, a proven treatment for conditions such as prostate and breast cancer, as well as precocious puberty, is prescribed in over 90 countries. Thierry Mauvernay, President, and Managing Director of Debiopharm, stated: \u201cWe channel over 90% of our revenues back into innovation, and our ambition extends beyond cancer treatment to the cure of cancer.\u201d<\/p>\n\n\n\n

Designed to meet current environmental standards, the new four-story Innovation building will span 2,400 square meters. The facility will be a hub for pioneering oncology research, further bolstering Debiopharm’s reputation in the pharmaceutical industry.<\/p>\n\n\n\n

Rapid expansion and groundbreaking innovations<\/h4>\n\n\n\n

Recent growth at Debiopharm’s Martigny site has been meteoric. C\u00e9dric Sager, CEO of Debiopharm Research & Manufacturing, remarked on the hiring spree, saying: \u201cIn the space of a year, we have taken on more than 50 new employees.\u201d The company projects that its expansion efforts will continue in the coming years, with a significant portion of the new recruits focusing on research and development.<\/p>\n\n\n\n

The company’s dedication to innovation in oncology is evidenced through its collaborations and research breakthroughs. Its collaboration with the HES-SO Valais-Wallis<\/a> has led to the development of two promising cancer-fighting technologies, Multilink\u2122 and AbYlink\u2122. Clinical trials using these groundbreaking techniques are set to commence as early as next year.<\/p>\n\n\n\n

Further strengthening its research credentials, Debiopharm recently committed CHF 1.1 million to a partnership with The School of Engineering\u2019s Institute of Life Science Technologies. This collaboration aims to develop therapeutic conjugates targeting cancer cells, a testament to Debiopharm’s commitment to innovative treatments that minimize side effects.<\/p>\n","protected":false},"excerpt":{"rendered":"

Debiopharm Research & Manufacturing has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150 to 200 in a year.<\/p>\n","protected":false},"author":6,"featured_media":20809,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[912,918,883,911,886],"class_list":["post-20808","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-biotech","tag-investment","tag-oncology","tag-pharma","tag-rd"],"acf":[],"yoast_head":"\nDebiopharm invests CHF 30M in Valais amidst workforce surge<\/title>\n<meta name=\"description\" content=\"Debiopharm has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150 to 200 in a year.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Debiopharm invests CHF 30M in Valais amidst workforce surge\" \/>\n<meta property=\"og:description\" content=\"Debiopharm has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150 to 200 in a year.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-26T15:14:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-26T15:14:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Debiopharm invests CHF 30 million in Valais amidst workforce surge\",\"datePublished\":\"2023-10-26T15:14:04+00:00\",\"dateModified\":\"2023-10-26T15:14:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/\"},\"wordCount\":366,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg\",\"keywords\":[\"Biotech\",\"Investment\",\"Oncology\",\"Pharma\",\"R&D\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/\",\"url\":\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/\",\"name\":\"Debiopharm invests CHF 30M in Valais amidst workforce surge\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg\",\"datePublished\":\"2023-10-26T15:14:04+00:00\",\"dateModified\":\"2023-10-26T15:14:05+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Debiopharm has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150 to 200 in a year.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"Established in the canton of Valais since 1989, Debiopharm is building a full-scale research and innovation campus in Martigny. | \u00a9 Sacha Bittel \/ Le Nouvelliste\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Debiopharm invests CHF 30 million in Valais amidst workforce surge\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Debiopharm invests CHF 30M in Valais amidst workforce surge","description":"Debiopharm has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150 to 200 in a year.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/","og_locale":"en_US","og_type":"article","og_title":"Debiopharm invests CHF 30M in Valais amidst workforce surge","og_description":"Debiopharm has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150 to 200 in a year.","og_url":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-10-26T15:14:04+00:00","article_modified_time":"2023-10-26T15:14:05+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Debiopharm invests CHF 30 million in Valais amidst workforce surge","datePublished":"2023-10-26T15:14:04+00:00","dateModified":"2023-10-26T15:14:05+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/"},"wordCount":366,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg","keywords":["Biotech","Investment","Oncology","Pharma","R&D"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/","url":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/","name":"Debiopharm invests CHF 30M in Valais amidst workforce surge","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg","datePublished":"2023-10-26T15:14:04+00:00","dateModified":"2023-10-26T15:14:05+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Debiopharm has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150 to 200 in a year.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg","width":1180,"height":811,"caption":"Established in the canton of Valais since 1989, Debiopharm is building a full-scale research and innovation campus in Martigny. | \u00a9 Sacha Bittel \/ Le Nouvelliste"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Debiopharm invests CHF 30 million in Valais amidst workforce surge"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/20808","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=20808"}],"version-history":[{"count":2,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/20808\/revisions"}],"predecessor-version":[{"id":20813,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/20808\/revisions\/20813"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/20809"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=20808"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=20808"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=20808"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}